NZ govt seeks more advice on GM liability
19 July, 2002 by Melissa TrudingerThe New Zealand government will seek further advice to supplement the Law Commission's report on liability issues for GMOs, which was released this week.
Scientists comment on proposed GM moratorium in South Australia
19 July, 2002 by Melissa TrudingerLeading South Australian agricultural scientists are alarmed by a proposed Bill by South Australian Democrat Ian Gilfillan to place a five-year moratorium on GMOs in South Australia.
Australian Animal Health Laboratory director appointed
18 July, 2002 by Melissa TrudingerCSIRO has appointed Dr Martyn Jeggo, international expert on livestock disease detection and control, as the new director of the Australian Animal Health Laboratory in Geelong.
New Burnet head to research edible vaccine research
18 July, 2002 by Tanya HollisAn edible vaccine project is among the research programs to be introduced by incoming Burnet Institute director Prof Steven Wesselingh.
CSL subsidiary strikes agreement with Novartis
18 July, 2002 by Tanya HollisCSL's Swiss subsidiary has struck a deal with drug company Novartis over the marketing and distribution of its intravenous immunoglobulin product.
Ambri appoints business development manager
18 July, 2002 by Tanya HollisBiosensor developer Ambri has appointed a new business development manager to drive sales of its SensiDx System throughout the Asia Pacific region.
Brisbane start-up Protagonist aims for more of a leading role
18 July, 2002 by Pete YoungDrug design start-up Protagonist is attempting to move up the food chain from a tools-oriented company to one with a proprietary interest in the molecules it designs and synthesises.
New Australian group in kidney bioengineering push
17 July, 2002 by Tanya HollisA consortium of Australia's top kidney scientists has come together with the ambitious goal of using stem cells to engineer a bioartificial organ.
New director for Ventracor
17 July, 2002 by Tanya HollisArtificial heart device developer Ventracor has appointed a new director to its ranks.
Peptech looks towards positive second half result in shareholder address
16 July, 2002 by Tanya HollisSydney company Peptech is hinging its hopes for a positive second half result on the issuing of US patents for its anti tumour nectrotising factor.
Interpret GM polls with caution: NZ academic
16 July, 2002 by Tanya HollisPolls claiming to illustrate community views on genetic modification should be interpreted with caution because they did not always take into account a person's knowledge of the topic, a New Zealand academic has warned.
Genesis R&D to study plant hormones
16 July, 2002 by Melissa TrudingerNew Zealand based Genesis Research and Development Corporation will get $NZ6 million from the Foundation for Research Science and Technology to discover and investigate new plant hormones and signalling processes.
Qld teams with US researchers in drought crop project
16 July, 2002 by Melissa TrudingerCollaborative agreements between researchers at the Queensland Department of Primary Industries and three major US universities - Texas A&M University, Texas Tech and the University of Missouri - could lead to development of drought resistant crops.
Get planning, physics head tells synchrotron users
15 July, 2002 by Melissa TrudingerPotential users of Australia's national synchrotron need to start planning now, according to Sir Peter Williams, president of the UK Institute of Physics and proponent of the synchrotron project.
ResMed shrugs off a nervous market
15 July, 2002 by Tanya HollisDespite being regarded as one of Australia's top three listed biotech stocks, sleep disorder specialist ResMed would probably rather forget 2002.
